Bio
With 20+ years driving technology-led advancement in healthcare, I serve as Chief Real-World Data and Analytics Officer at Norstella, where I lead the use of real-world data to power AI-driven decision-making across the pharmaceutical industry. My background as a Doctor of Pharmacy (Pharm.D.) with deep expertise in pharmacy automation shapes how I approach AI in pharma: I treat it not as novelty but as a discipline that’s only as trustworthy as the real-world evidence beneath it. That conviction guides my work building AI that turns claims, EHR, and linked patient journeys into decisions that actually move healthcare outcomes. My leadership extends to my roles as a successful entrepreneur and Founder and CEO of Skipta — all reflecting a career-long commitment to aligning strategic goals with patient-focused, technology-driven solutions.
What makes Norstella’s AI different?
Norstella’s AI is built on something no one can scrape or replicate: our own proprietary data spanning the entire drug journey — from clinical pipeline and regulatory intelligence to market access, claims, EHR, unstructured clinical text, and linked patient journeys. That’s the difference between AI that guesses from generic web content and AI grounded in the actual evidence of how drugs get developed, approved, and reach patients. Atlas AI by Norstella turns that foundation into a closed loop — Insight, Target, Trigger, Activate, Measure — so it doesn’t just answer questions, it drives action and proves outcomes.
What can pharma teams do now that was not possible two years ago?
Two years ago, answering a real question — which physicians are treating the right patients, where a therapy is gaining or losing ground, what the data says about an emerging cohort — meant a six-week analytics project, a data scientist, and a queue. With Norstella’s AI, teams now ask that question in plain language and get an answer grounded in billions of records — claims, EHR, unstructured clinical notes, and linked patient journeys — in seconds. The expertise that used to live with a handful of specialists is now in the hands of every commercial, medical, and market access team, working in the flow of a conversation.
How can AI accelerate the journey from pipeline to patient?
AI compresses the distance between insight and activation — identifying the right patients and prescribers, triggering the right outreach at the right moment, and measuring impact in a single connected loop. That’s how you turn a promising pipeline asset into patients reached, faster.